DNA antibody constructs for use against middle east respiratory syndrome coronavirus
US11230592B2 · kind B2 · utility
1Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 27, 2018 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | Sep 27, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein is a composition including a recombinant nucleic acid sequence that encodes an antibody to a Middle East Respiratory Syncytial Coronavirus (MERS-CoV) viral antigen. Also disclosed herein is a method of generating a synthetic antibody in a subject by administering the composition to the subject. The disclosure also provides a method of preventing and/or treating an MERS-CoV virus infection in a subject using said composition and method of generation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.